Related Experiment Videos

The (Ca2+, Mg2+)-ATPase activity in erythrocyte membranes from essential hypertensive patients

A Gutiérrez1, R Ariza, A C Frati-Munari

  • 1Departamento de Medicina Interna, Hospital de Especialidades, Centro Médico La Raza, IMSS, México, D.F.

Archivos De Investigacion Medica
|July 1, 1991
PubMed

Insights

Erythrocyte calcium-ATPase activity showed no baseline differences between hypertensive and normotensive individuals. Caution is advised when using EGTA buffers in assays due to potential misinterpretation of results in hypertension research.

Area of Science:

  • Biochemistry
  • Cardiovascular Physiology
  • Cellular Biology

Background:

  • Erythrocyte (Ca2+,Mg2+)-ATPase is crucial for calcium homeostasis.
  • Previous studies on erythrocyte ATPase in hypertension have yielded conflicting results.

Purpose of the Study:

  • To compare erythrocyte (Ca2+,Mg2+)-ATPase activity between hypertensive and normotensive subjects.
  • To investigate the influence of EGTA and calmodulin on ATPase activity in both groups.

Main Methods:

  • Assay of erythrocyte (Ca2+,Mg2+)-ATPase activity.
  • Comparison between 12 hypertensive and 14 normotensive subjects.
  • Evaluation of EGTA and calmodulin effects on enzyme activity.

Main Results:

  • No significant differences in basal calcium-ATPase activity were observed between groups.
  • EGTA showed a partial stimulatory effect, with blunted calmodulin stimulation in both groups.
  • Calmodulin significantly stimulated ATPase activity (four-fold) when EGTA was absent and calcium was 100 uM.

Conclusions:

  • Use of EGTA buffers in erythrocyte calcium-ATPase assays requires caution, especially when comparing hypertensive and normotensive patients.
  • EGTA-sensitive enzymes may lead to erroneous interpretations, potentially explaining discrepancies in hypertension research.
  • Findings highlight the importance of assay conditions for understanding calcium transport in hypertension.

Related Concept Videos